Editorial Policy

Last updated September 2026.

Every page here answers one question, states the answer before the explanation, and says which week of the titration schedule it is talking about. If a page cannot carry Marisol Vega’s name, it does not publish.

Why every page names a week

Semaglutide is not experienced as a drug, it is experienced as a timeline. Almost nobody arrives here asking “is this normal?” in the abstract — they are asking it about a particular week of a particular step. A side-effect page that does not say which point in the schedule it means is answering a question nobody asked, and it is the category’s main failure. That is why the schedule track sits at the top of the dosing and side-effect pages, why every one of those pages states the step it answers for, and why the track does not appear anywhere it would just be decoration.

What the site will not do is tell you what your own step will feel like. A sentence about how side effects track the schedule is published here only when a document says so — the approved label, or a published trial — and the page that carries it lists that document at its foot. Where nothing says so, the sentence is cut rather than hedged.

What gets cited, and what does not get written

• Dosing figures come from published prescribing information. Never from memory, and never from another website’s summary of it.
• No incidence figure, percentage or total appears on this site unless the source states that number. A figure that is close enough is a wrong figure.
• Quotations are taken from the source document itself, and the citation names the document, not a search result that led to it.
• Where the honest answer is “this is not established,” the page says that rather than picking the more useful-sounding of two claims.

Compounded and brand-name products

Where a page touches on compounded semaglutide, it states what is known and stops. It does not imply that a compounded product is equivalent to a brand-name one, and it does not imply that it is inferior. Both would be claims this site cannot support.

How prices are read

• A price is read from the provider’s own page, and the date it was read is printed beside it. A price with no reading date does not publish.
• Every figure is printed with its billing cycle and the dose it buys. A semaglutide price with no dose attached does not mean anything, because the same seller often charges differently at 0.25 mg and at 2.4 mg.
• Where a figure is a “from” price, an introductory rate or a prepay total, it is labeled as one rather than presented as a standing monthly rate.
• A provider writing in to correct a price is treated as a lead to re-read the page, not as a price. We re-walk the record; we do not apply their number.

What a partner relationship changes

It changes where a seller is shown, and nothing that is said about it. A partner is listed first on the seller index and in the home page’s seller cards, the offer card beside a page shows only partners, and every partner link says we may be paid, next to the link, every time it appears. It does not change a figure, a verdict, or whether an unflattering fact gets printed. Providers who pay us nothing sit in the same tables, on the same markup, and are not written about more harshly to make the partner rows look better. What a commercial relationship does and does not reach is set out in full on the disclosure page.

Research and advertising

Research may have a clearly labeled paid provider widget beside the article, or after it on mobile. Provider advertising is separate from the clinical discussion and does not establish that a treatment or service is suitable for the reader. Tools and policy pages carry no provider advertising.

Corrections

Marisol Vega owns the corrections log. When something here is wrong, the corrections page says what was wrong, when it was published, and when it was fixed — and the page that carried the error is fixed too. A correction does not correct the page it sits on.

How the roster was built

Every seller on this site comes from one price research pass: 3327 figures read across 591 sellers on September 2026, of which 410 figures across 117 sellers carried a rate that could be used at all. A seller is published here only if at least one of its semaglutide figures cleared three separate bars.

• It is published, not merely present. A figure that exists in a page’s markup but that no reader sees is not a published price. That filter is applied once, when the data is imported, so no count on this site can disagree with any row rendered from it.
• The seller tied the figure to a basis itself. 38 figures in the research had a dose inferred from how close it sat to the number rather than from anything the seller wrote. Those were refused. A dose guessed from nearness reads on the page exactly like a dose the seller quoted, and a reader has no way to tell them apart.
• That basis is carried as its own field, and it says which kind it is. a large minority of the sellers here do not price by dose at all — they state one price and say it holds at every dose. That is a pricing policy, and printing it in a “price at 1 mg” column would put a claim in a company’s mouth that it never made. Every figure on this site says which of the two it is.

Where a seller reaches this site, its outbound link is derived by one stated rule — the page its first published semaglutide figure appears on, falling back to the page the figure was actually printed on — and each review says which of those it used. Provider links use our /go/ redirects. Where an approved affiliate program exists, its recorded tracking destination may be used. Scientific and regulatory citations link directly to their sources.

What this does not include: a re-read cadence. Every figure here was read once, on the date printed beside it, and has not been re-read since. A price on this site is a reading, not a quote and not an offer.